Antineoplastic Combined Chemotherapy Protocols Summary Report | CureHunter
Antineoplastic Combined Chemotherapy Protocols: The use of two or more chemicals simultaneously or sequentially in the drug ... Clinical Protocols*Antineoplastic Protocols: 26*Antineoplastic Combined Chemotherapy Protocols: 23*EVAC protocol: 429 ... Antineoplastic Combined Chemotherapy Protocols. Subscribe to New Research on Antineoplastic Combined Chemotherapy Protocols ... Cancer Chemotherapy Protocol; Chemotherapy Protocol, Antineoplastic; Chemotherapy Protocol, Cancer; Chemotherapy Protocols, ...
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
"Radiation Treatment for Cervical Esophagus: Patterns of Practice Study in Canada, 1996" by Patricia...
The majority of the patients had combined cisplatin-based chemoradiation. The isocenter was not used consistently as a dose ... The most frequently used prescription dose was 60 Gy/30 fractions/6 weeks, given with concurrent chemotherapy. Dose ... Antineoplastic Combined Chemotherapy Protocols, *Canada, *Cancer Care Facilities, *Combined Modality Therapy, *Esophageal ... The majority of the patients had combined cisplatin-based chemoradiation. The isocenter was not used consistently as a dose ...
Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working...
Forty infants have subsequently been treated on a protocol incorporating further intensification with an option for hi … ... Antineoplastic Combined Chemotherapy Protocols / therapeutic use* * Bone Marrow Transplantation* * Cytarabine / adverse effects ... These results show the susceptibility of infants to the toxicity of intensive chemotherapy and do not support the use of short ... have subsequently been treated on a protocol incorporating further intensification with an option for high-dose chemotherapy ...
Connie Rong Shi, M.D. | Harvard Catalyst Profiles | Harvard Catalyst
Cytoreduction and HIPEC in the Netherlands : nationwide long-term outcome following the Dutch protocol | Lund University...
Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Signet Ring Cell/mortality, Chemotherapy, Cancer, ... Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Signet Ring Cell/mortality; Chemotherapy, Cancer, ... combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis of colorectal origin in the ... combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis of colorectal origin in the ...
Effects of adjuvant chemotherapy on specific and non-specific immune mechanisms. | CureHunter
Effects of adjuvant chemotherapy on specific and non-specific immune mechanisms. - C C Zielinski, C Müller, E Kubista, A ... Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use) *B-Lymphocytes (drug effects) ... Effects of adjuvant chemotherapy on specific and non-specific immune mechanisms.. Abstract. Adjuvant chemotherapy is a well ... However, very little is known about the late effects of adjuvant chemotherapy and its influence upon the function of a series ...
Portal Regional da BVS
Antineoplastic Combined Chemotherapy Protocols, Biomedical Research, 50053, 35493, Molecular Biology, 37643, Men's Health ... Antineoplastic Combined Chemotherapy Protocols, Biomedical Research, 50053, 35493, Molecular Biology, 37643, Men's Health ... Antineoplastic Protocols, Combined Modality Therapy, Pathological Conditions, Signs and Symptoms, Pathology, Clinical, Drug ... Antineoplastic Protocols, Combined Modality Therapy, Pathological Conditions, Signs and Symptoms, Pathology, Clinical, Drug ...
List of MeSH codes (E02) - Wikipedia
... antineoplastic combined chemotherapy protocols MeSH E02.190.044.080 - acupressure MeSH E02.190.044.105 - acupuncture analgesia ... antineoplastic combined chemotherapy protocols MeSH E02.319.162.150 - antibiotic prophylaxis MeSH E02.319.300.253 - delayed- ... antineoplastic combined chemotherapy protocols MeSH E02.319.310.075 - antiretroviral therapy, highly active MeSH E02.319. ...
Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical...
Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum. | Emmes
Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diarrhea; Enteritis; Female; ... One other patient on the chemotherapy arm died of acute nonlymphocytic leukemia. The authors conclude that combined ... This schedule of combined modality therapy is not only effective but appears to have tolerable toxicity, because of the ... Severe toxicity in the combined therapy arm was significantly worse (P less than 0.001) than in either single modality arm. ...
100 results in SearchWorks articles
Medical Science Monitor | Effect of Combined Treatment Using Wilfortrine and Paclitaxel in Liver Cancer and Related Mechanism -...
The combined therapy had better treatment efficacy compared to either of those drugs alone (p,0.05). CONCLUSIONS:The combined ... This study thus investigated the potential effect of paclitaxel combined with wilfortrine on cultured liver cancer cells and ... MATERIAL AND METHODS:Liver cancer cell line HpeG2 was divided into control, paclitaxel, wilfortrine, and combined treatment ... Keywords: Antineoplastic Combined Chemotherapy Protocols - therapeutic use, Alkaloids - therapeutic use, Blotting, Western, ...
Medical Science Monitor | Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received...
5-FU TDM significantly reduced the toxicity of chemotherapy and improved its efficacy. The Study Group (30/289) showed a lower ... patients receiving fluorouracil-based chemotherapy is still unclear. MATERIAL AND METHODS:A total of 207 patients (Study Group ... and can be routinely used in 5-FU-based chemotherapy. ... Antineoplastic, Antineoplastic Combined Chemotherapy Protocols ... CHEMOTHERAPY AND PATIENTS: From March 2016 to August 2018, advanced CRC patients who received chemotherapy containing 5-FU ( ...
Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2.
Antineoplastic Combined Chemotherapy Protocols. *1112 Oncology and Carcinogenesis. Citation. APA Chicago ICMJE ... Triple-negative breast cancer (TNBC) is an aggressive malignancy for which cytotoxic chemotherapy remains the backbone of ... protecting them from chemotherapy-induced damage and enhancing immune activity. Administration of trilaciclib prior to ... that induces transient cell cycle arrest of hematopoietic stem and progenitor cells and immune cells during chemotherapy ...
Lymphoma b cell. Medical search
Antineoplastic Combined Chemotherapy Protocols (ACCP) are standardized treatment plans that combine multiple chemotherapy drugs ... Antineoplastic Combined Chemotherapy Protocols (ACCP) are a type of chemotherapy treatment used to treat cancer. They involve ... Antineoplastic Combined Chemotherapy Protocols. The use of two or more chemicals simultaneously or sequentially in the drug ... Lymphocyte ActivationImmunophenotypingFlow CytometryAntineoplastic Combined Chemotherapy ProtocolsImmunohistochemistryPrognosis ...
Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER...
"Assessment of Residual Cancer Burden and Event-Free Survival in Neoadj" by W Fraser Symmans, Christina Yau et al.
... then 12 weeks of cyclophosphamide/doxorubicin chemotherapy followed by surgery. MAIN OUTCOMES AND MEASURES: Residual cancer ... investigational agents in combination with chemotherapy vs chemotherapy alone in adult women with stage 2/3 breast cancer at ... washington; seattle; swedish; swedish cancer; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; ... investigational agents in combination with chemotherapy vs chemotherapy alone in adult women with stage 2/3 breast cancer at ...
Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate...
Antineoplastic Combined Chemotherapy Protocols; Vincristine; Cranial Irradiation; Injections, Spinal ... Combined Modality Therapy; Antimetabolites, Antineoplastic; Male; Recurrence; Infant; Female; Survival Analysis; Child, ... Conclusion: Cranial irradiation may be omitted safely in IR ALL patients treated with BFM-based intensive chemotherapy when ... Conclusion: Cranial irradiation may be omitted safely in IR ALL patients treated with BFM-based intensive chemotherapy when ...
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic...
Antineoplastic Combined Chemotherapy Protocols. Cost-Benefit Analysis. Deoxycytidine. Disease-Free Survival. Humans. Italy. ...
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple...
Antineoplastic Combined Chemotherapy Protocols * Carmustine * Cytarabine * Etoposide * Female * Hematopoietic Stem Cell ... These changes did not occur in patients with lymphoma receiving the same chemotherapy for AHSCT.The EFS in our MS cohort is ... cytometry was performed for evaluation of post-transplant IR in both MS and lymphoma patients receiving the same chemotherapy ...
Salivary BPIFA1 (SPLUNC1) and BPIFA2 (SPLUNC2 A) are modified by head and neck cancer radiotherapy<...
Casey Gashti's research topics | Profiles RNS
RMMG - Revista Médica de Minas Gerais
"Amivantamab compared with real-world therapies in patients with advanc" by Anna Minchom, Santiago Viteri et al.
... and platinum-based chemotherapy (16.3%). Overall response rate was 40% among amivantamab-treated patients and 16% among ... prior platinum-based chemotherapy, and performance status score ≤ 1. Duplicate external controls were identified using a ... Most common therapies received by external controls were non-platinum-based chemotherapy (25.1%), immuno-oncology therapies ( ... who progressed on prior platinum-based chemotherapy. External controls can provide context for interpreting amivantamab ...
Antineoplastic Protocols | Profiles RNS
Antineoplastic Combined Chemotherapy Protocols. publications Timeline , Most Recent This graph shows the total number of ... "Antineoplastic Protocols" by people in this website by year, and whether "Antineoplastic Protocols" was a major or minor topic ... "Antineoplastic Protocols" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical ... Below are the most recent publications written about "Antineoplastic Protocols" by people in Profiles. ...
Laserphototherapy on treatment of chemotherapy-induced oral mucositis: case report
Palavras-chave : Antineoplastic Combined Chemotherapy Protocols; Mucositis; Laser Therapy; Low-level. · resumo em Português · ... Laserphototherapy on treatment of chemotherapy-induced oral mucositis: case report. Rev. Assoc. Paul. Cir. Dent. [online]. 2013 ... after 5-fluorouracil and cisplatin chemotherapy. A diode laser, 0.04 cm2 of spot area, 660nm, 40mW, 6J/cm2 and 0.24J per point ... is a debilitating acute inflammation of patients undergoing cancer therapy including high doses of chemotherapy or head and ...